诺泰生物(688076)每日收评(06-10)

Group 1 - The stock of Nuotai Bio (688076) has a comprehensive score of 56.66, indicating a strong performance [1] - The main cost analysis shows the current price at 56.69 yuan, with a 5-day cost of 52.44 yuan, a 20-day cost of 53.45 yuan, and a 60-day cost of 52.16 yuan [1] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - The short-term resistance level is at 55.18 yuan, while the short-term support level is at 48.86 yuan [2] - The stock has broken through the short-term resistance level, suggesting potential short-term strength, and also the mid-term resistance level, indicating possible mid-term strength [2] - The K-line pattern shows a "Red Three Soldiers" formation, indicating a potential bottoming out and recovery [2] Group 3 - On June 10, 2025, the net inflow of main funds was 57.82 million yuan, accounting for 7% of the total transaction amount [2] - The net inflow from large orders was 29.53 million yuan, while the net inflow from super large orders was 28.29 million yuan [2] - Retail investors contributed a net inflow of 41.05 thousand yuan [2] Group 4 - The latest financial data shows earnings per share at 0.69 yuan, operating profit at 178 million yuan, and net profit at approximately 147.87 million yuan [2] - The sales gross margin stands at 70.204% [2] - The stock is associated with sectors such as medical services (0.15%), CRO (1.13%), influenza (0.35%), and hepatitis concepts (0.98%) [2]